Z-2201-2021 Class III Terminated
FDA device recall Z-2201-2021 was initiated by Stanbio Laboratory, LP on Jul 12, 2021 and is designated Class III. Reason for recall: Deterioration in the stability of the reagents which has resulted in lower than expected or out of range Quality Control values. The recall status is terminated (terminated Mar 29, 2022). Affected quantity: 100 units.
Recall details
- Product Type
- Devices
- Report Date
- Aug 11, 2021
- Initiation Date
- Jul 12, 2021
- Termination Date
- Mar 29, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 100 units
Product description
Reason for recall
Distribution pattern
Worldwide distribution - U.S. Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KY, LA, MA, MD, MI, MO, NC, NH, NJ, NV, NY, OH, OK, OR, PA, Puerto Rico, RI, TN, TX, VA, VT, WA, WI, and WV. The countries of Australia, Canada, Chile, Federal Republic of Germany, Hong Kong, Singapore, Taiwan, Thailand, United Kingdom, and Viet Nam.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2201-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026